NASDAQ:BCLI

Brainstorm Cell Therapeutics Earning Date

USA |NASDAQ |USD

BCLI Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Feb 2, 2022 Dec 2021 $-0.21 - $-0.37
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Feb 2, 2022 Dec 2021 $0.00 - $0.00

Brainstorm Cell Therapeutics's next earnings date is Wednesday, Feb 2, 2022 for the fiscal quarter ending Dec 2021.

BCLI Earnings Date & History Chart

BCLI Earnings & Revenue Forecast

BCLI Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 3 $-0.21 $-0.24 $-0.17
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 3 $-0.82 $-1.02 $-0.70
Dec 2022 3 $-0.94 $-1.25 $-0.79

BCLI Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.21 $-0.21 $-0.22
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.82 $-0.82 $-0.80
Dec 2022 0 / 0 $-0.94 $-0.94 $-0.53

BCLI Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 3 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 3 $0.00 $0.00 $0.00
Dec 2022 3 $12.63M $0.00 $37.90M

BCLI Earnings Date & Revenue History

BCLI Earnings History

|
Show More
Show More

BCLI Revenue History

|
Show More
Show More

Brainstorm Cell Therapeutics Next Earnings Date & Report

BCLI Next Earnings Date & Report Preview: Dec 2021 (FQ)

BCLI's next earnings date is Wednesday, Feb 2, 2022 for the fiscal quarter ending Dec 31, 2021.

According to analysts, the average EPS estimation for Brainstorm Cell Therapeutics's next quarterly earnings is $-0.21, with a low EPS estimation of $-0.24, and a high estimation of $-0.17.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.21, the last 2 month trend is $-0.21, and the 3 month trend is $-0.22.

Based on analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.

Brainstorm Cell Therapeutics Previous Earnings Dates & Reports

BCLI Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Brainstorm Cell Therapeutics's previous earnings date was Oct 13, 2021 for its fiscal quarter ended Sep 30, 2021.

BCLI Previous Earnings Date & Report Recap: Dec 2020 (FY)

Brainstorm Cell Therapeutics's previous annual earnings date was Feb 4, 2021 for its fiscal year ended Dec 31, 2020.

BCLI's earnings per share (EPS) was $-1.08, missing the consensus analysts forecast of $-0.89 by 21.35% , and lower than the previous year's EPS (Dec 2019) by 1.89%.

Revenues were $0.00.

The company reported a net income of $-31.81M.

Brainstorm Cell Therapeutics reported a free cash flow of $-35.57M for its fiscal year, compared to $-11.72M a year ago.

The company ended the fiscal year with $7.22M in total debt, an increase of 205.03% compared to the previous year.